ArticleFrontiers in oncology2021

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations.

Zhengyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.